Fig. 6

The association of ALG3 expression with prognosis in breast cancer patients. a, b LRFS and OS of breast cancer patients, stratified by high and low ALG3 expression, were analyzed by Kaplan-Meier analysis with log-rank test. c, d Multivariate Cox regression analysis to evaluate the significance of the association between ALG3 expression and prognosis were performed. e Representative images of ALG3 expression level detected by IHC were shown. f Statistical graph of ALG3 expression in patients who relapsed in 5 years or not was shown. g LRFS of breast cancer patients who underwent radiotherapy, stratified by ALG3 expression, was analyzed by Kaplan-Meier analysis with log-rank test. h LRFS of breast cancer patients who have not received radiotherapy, stratified by ALG3 expression, was analyzed by Kaplan-Meier analysis with log-rank test. i LRFS of breast cancer patients with ALG3 low-expression, stratified by undergoing radiotherapy or not, was analyzed by Kaplan-Meier analysis with log-rank test. j LRFS of breast cancer patients with ALG3 high-expression, stratified by undergoing radiotherapy or not, was analyzed by Kaplan-Meier analysis with log-rank test. k A schematic model of how ALG3 regulating TGF-β pathway was shown